Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating Acoustic Cluster Therapy (ACT) with chemotherapy for locally advanced pancreatic adenocarcinoma is current…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial of ZM008, an anti-LLT1 antibody, given as a single agent and then in combination with toripalimab in patients with ad…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations [Phase 3]
A Phase 3 study is evaluating chemotherapy with or without panitumumab for unresectable, locally advanced, or metastatic pancreatic cancer w…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement. [NA]
A clinical trial is evaluating the feasibility and safety of combining pancreatic tumor surgery with HIPEC for pancreatic cancer with perito…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 clinical trial from Wake Forest University Health Sciences is evaluating neoadjuvant chemotherapy for borderline resectable and lo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread [Phase 2]
Phase 2 trial update evaluating two regimens for older patients with metastatic pancreatic cancer: gemcitabine plus nab-paclitaxel versus a …
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Anatomical-Clinical Base of Adenocarcinoma Pancreatic
A recruiting clinical trial sponsored by University Hospital, Toulouse, focusing on pancreatic adenocarcinoma.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer [Phase 1]
This first-in-human Phase 1 study investigates an implantable iontophoresis device delivering gemcitabine once weekly or twice weekly for no…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT [Phase 1, Phase 2]
This record summarizes ongoing Phase 1 and Phase 2 clinical trials evaluating prehabilitation strategies for ovarian cancer (including epith…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers [Phase 2]
A Phase 2 study investigating the use of FAPI-PET imaging for initial screening of cholangiocarcinoma and pancreatic adenocarcinoma, status …
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma [NA]
The study investigates whether GATA6 expression can predict response to peri-operative chemotherapy in resectable pancreatic cancer, with th…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
A Mayo Clinic-sponsored clinical trial update recruiting to collect medical information and tissue samples from patients with pancreatic can…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: TR-002 for the Treatment of Advanced, Unresectable or Metastatic Solid Tumors and Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma [Phase 1]
A Phase 1 clinical trial evaluating TR-002 for advanced unresectable or metastatic solid tumors and unresectable or metastatic pancreatic ad…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: FAZA PET/MRI Pancreas [NA]
A FAZA PET/MRI imaging study for pancreatic cancer that is unresectable or locally advanced is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating nab-paclitaxel plus cisplatin and gemcitabine in combination with Tumor Treating Fields for metastatic p…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer. [EARLY_Phase 1]
An early-phase exploratory clinical study is evaluating Claudin18.2-targeted Activated Dendritic Cells and Claudin18.2-targeted CAR-T therap…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Risk-adapted Adjuvant Chemotherapy Guided by the Tumour Stage for Operated Pancreatic Adenocarcinoma Following Neoadjuvant Chemotherapy With mFOLFIRINOX [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating risk-adapted adjuvant chemotherapy guided by tumor stage after neoadjuvant mFOLFIRINOX in patien…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5) [Phase 1, Phase 2]
This clinical trial update describes the PREOPANC-5 study evaluating neoadjuvant triple therapy for localized or borderline resectable pancr…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation [Phase 2]
This is a Phase 2 clinical trial update evaluating HRS-4642 in combination with Nimotuzumab and chemotherapy for borderline resectable pancr…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma [Phase 1]
Phase 1 clinical trial update for padeliporfin vascular-targeted photodynamic therapy in locally advanced unresectable pancreatic adenocarci…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Predictive Value of Transcriptome-based OncoTreat/Oncotarget and Organoid Testing in Metastatic Pancreatic Cancer.
This clinical trial investigates whether transcriptome-based OncoTreat/Oncotarget profiling and patient-derived organoid testing can predict…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer. [Phase 1, Phase 2]
A Phase 1/2 trial to evaluate the safety and efficacy of XER-001 (amifostine delivered nasoduodenally) in combination with stereotactic body…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer [Phase 3]
A Phase 3 clinical trial update evaluating the use of standard chemotherapy before and after surgery for resectable pancreatic cancer is cur…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: ZN-c3 + Gemcitabine in Pancreatic Cancer [Phase 2]
Phase 2 trial update on the combination of ZN-c3 with gemcitabine for pancreatic cancer, with the study currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma. [NA]
Completed a clinical trial evaluating the use of circulating tumor cells for diagnosing pancreatic adenocarcinoma.